Background
Methods
Gene | RT primer | |
---|---|---|
U6 | 5’CGCTTCACGAATTTGCGTGTCAT3’ | |
miR-RT Primer | 5’GTCGGTGTCGTGGAGTCGTTTGCAATTGCACTGGATTTTTTTTTTTTTTTTTTV3’ | |
V = A, G, C | ||
Gene | Forward primer (5’–3’) | Reversed primer (5’–3’) |
ssc-miR-10b | TACCCTGTAGAACCGAATTTGT | GTCGGTGTCGTGGAGTCG |
ssc-miR-30a-5p | TGTAAACATCCTCGACTGGAAG | GTCGGTGTCGTGGAGTCG |
ssc-miR-16 | TAGCAGCACGTAAATATTGGC | GTCGGTGTCGTGGAGTCG |
ssc-miR-17-5p | CAAAGTGCTTACAGTGCAGGTAG | GTCGGTGTCGTGGAGTCG |
ssc-miR-192 | CTGACCTATGAATTGACA | GTCGGTGTCGTGGAGTCG |
ssc-miR-21 | TAGCTTATCAGACTGATGTTGA | GTCGGTGTCGTGGAGTCG |
ssc-miR-19b | TGTGCAAATCCATGCAAAAC | GTCGGTGTCGTGGAGTCG |
ssc-miR-18a | TAAGGTGCATCTAGTGCAGATA | GTCGGTGTCGTGGAGTCG |
ssc-miR-152 | TCAGTGCATGACAGAACTTGG | GTCGGTGTCGTGGAGTCG |
ssc-miR-novel-chr13_10861 | TTCAAGTAACCCAGGATAGGCT | GTCGGTGTCGTGGAGTCG |
U6 | TCGCTTTGGCAGCACCTAT | AATATGGAACGCTTCGCAAA |
Results
Annotation | Normalized read counts | length | type | FC | Number of target genes | |
---|---|---|---|---|---|---|
infected | control | |||||
ssc-miR-10b | 42,588 | 1162 | 22 | Up | 36.35 | 738 |
ssc-miR-192 | 3769 | 102 | 21 | Up | 33.74 | 718 |
ssc-miR-20a | 2432 | 116 | 22 | Up | 19.38 | 1490 |
ssc-miR-296-3p | 195 | 3 | 21 | Up | 15.77 | 1863 |
ssc-miR-novel-chr17-18987 | 195 | 3 | 19 | Up | 15.77 | 1864 |
ssc-miR-92b-3p | 2215 | 133 | 22 | Up | 15.56 | 1757 |
ssc-miR-30a-5p | 98,034 | 6320 | 22 | Up | 15.49 | 1147 |
ssc-miR-novel-chr12-7961 | 1886 | 191 | 22 | Up | 9.43 | 1357 |
ssc-miR-novel-chr14-13888 | 582 | 58 | 23 | Up | 8.71 | 1368 |
ssc-miR-34a | 358 | 37 | 22 | Up | 7.83 | 1663 |
ssc-miR-novel-chr16-17559 | 55 | 0 | 22 | Up | 6.5 | 1610 |
ssc-miR-novel-JH11865-1-42 | 55 | 0 | 23 | Up | 6.5 | 1727 |
ssc-miR-17-5p | 2868 | 438 | 23 | Up | 6.42 | 1443 |
ssc-miR-16 | 11,873 | 1891 | 22 | Up | 6.25 | 1763 |
ssc-miR-22-3p | 2267 | 365 | 22 | Up | 6.07 | 1487 |
ssc-miR-146b | 75 | 3 | 21 | Up | 6.07 | 1139 |
ssc-miR-155-5p | 426 | 62 | 22 | Up | 6.06 | 1146 |
ssc-miR-novel-chr2-20965 | 52 | 1 | 23 | Up | 5.64 | 1147 |
ssc-miR-novel-chrx-40705 | 758 | 147 | 22 | Up | 4.89 | 811 |
ssc-miR-221-3p | 758 | 147 | 22 | Up | 4.89 | 811 |
ssc-miR-301 | 114 | 17 | 23 | Up | 4.59 | 1509 |
ssc-miR-191 | 741 | 156 | 23 | Up | 4.52 | 695 |
ssc-miR-novel-chr6-31692 | 46 | 3 | 22 | Up | 4.30 | 2019 |
ssc-miR-181a | 637 | 147 | 24 | Up | 4.12 | 1221 |
ssc-miR-18a | 88 | 9541 | 22 | Down | 0.0102 | 995 |
ssc-miR-novel-chr9-37990 | 20 | 1752 | 23 | Down | 0.0170 | 1512 |
ssc-miR-novel-chr9-39041 | 20 | 1752 | 23 | Down | 0.0170 | 1512 |
ssc-miR-novel-chr6-30729 | 13 | 1317 | 22 | Down | 0.0173 | 1083 |
ssc-miR-424-5p | 33 | 2182 | 22 | Down | 0.0196 | 1817 |
ssc-miR-31 | 55 | 3118 | 22 | Down | 0.0208 | 1149 |
ssc-miR-novel-chrX-41190 | 0 | 431 | 21 | Down | 0.0227 | 335 |
ssc-miR-novel-chr11-6750 | 7 | 547 | 18 | Down | 0.0305 | 1406 |
ssc-miR-152 | 332 | 9880 | 21 | Down | 0.0346 | 1161 |
ssc-miR-542-5p | 0 | 277 | 21 | Down | 0.0348 | 732 |
ssc-miR-499-5p | 7 | 472 | 21 | Down | 0.0353 | 974 |
ssc-miR-142-3p | 0 | 238 | 22 | Down | 0.0403 | 887 |
ssc-miR-135 | 0 | 235 | 23 | Down | 0.0408 | 1602 |
ssc-miR-194a | 13 | 541 | 21 | Down | 0.0417 | 842 |
ssc-miR-361-5p | 20 | 704 | 22 | Down | 0.0420 | 867 |
ssc-miR-185 | 59 | 1621 | 22 | Down | 0.0423 | 2285 |
ssc-miR-193a-5p | 0 | 201 | 22 | Down | 0.0474 | 1142 |
ssc-miR-novel-chr5-29676 | 0 | 199 | 23 | Down | 0.0478 | 1066 |
ssc-miR-183 | 156 | 3132 | 23 | Down | 0.0528 | 1087 |
ssc-miR-29c | 16 | 366 | 22 | Down | 0.0691 | 1120 |
ssc-miR-novel-chr5-29857 | 42 | 736 | 19 | Down | 0.0697 | 1711 |
ssc-miR-29a | 267 | 3939 | 23 | Down | 0.0701 | 1079 |
ssc-miR-19a | 498 | 6339 | 23 | Down | 0.0800 | 1436 |
ssc-miR-19b | 1161 | 14,587 | 23 | Down | 0.0802 | 1299 |
ssc-miR--novel-chr13_10861 | 169 | 1483 | 22 | Down | 0.1199 | 857 |
ssc-miR-21 | 52,611 | 382,830 | 22 | Down | 0.1374 | 789 |
GO.ID | Term | Count |
P-value |
---|---|---|---|
Biological process | |||
GO:0009987 | cellular process | 1782 | 1.0102E-05 |
GO:0008152 | metabolic process | 1350 | 2.44953E-27 |
GO:0065007 | biological regulation | 1260 | 0.000424577 |
GO:0044238 | primary metabolic process | 1231 | 5.99319E-26 |
GO:0044237 | cellular metabolic process | 1221 | 1.70495E-28 |
GO:0050789 | regulation of biological process | 1192 | 0.002408788 |
GO:0050794 | regulation of cellular process | 1147 | 0.000216533 |
GO:0002376 | immune system process | 273 | 1.35305E-08 |
GO:0006955 | immune response | 163 | 1.37682E-05 |
GO:0000165 | MAPK cascade | 79 | 3.28195E-05 |
Cellular Component | |||
GO:0044464 | cell part | 1772 | 1.04304E-42 |
GO:0005623 | cell | 1772 | 1.25735E-42 |
GO:0005622 | intracellular | 1589 | 1.48695E-38 |
GO:0044424 | intracellular part | 1512 | 9.75601E-38 |
GO:0043226 | organelle | 1258 | 3.15768E-22 |
GO:0043229 | intracellular organelle | 1255 | 5.59497E-22 |
GO:0005737 | cytoplasm | 1146 | 1.88382E-25 |
GO:0043227 | membrane-bounded organelle | 1131 | 3.1329E-23 |
GO:0043231 | intracellular membrane-bounded organelle | 1129 | 3.31685E-23 |
GO:0044444 | cytoplasmic part | 886 | 1.59538E-15 |
Molecular Function | |||
GO:0005488 | binding | 1781 | 7.2806E-35 |
GO:0005515 | protein binding | 1406 | 1.01651E-30 |
GO:0003824 | catalytic activity | 791 | 4.12422E-11 |
GO:0043167 | ion binding | 425 | 2.86598E-07 |
GO:0043169 | cation binding | 423 | 3.71961E-07 |
GO:0046872 | metal ion binding | 416 | 4.07808E-07 |
GO:0003676 | nucleic acid binding | 368 | 0.010086661 |
GO:0036094 | small molecule binding | 366 | 1.33205E-09 |
GO:0000166 | nucleotide binding | 341 | 4.24208E-09 |
GO:0097159 | organic cyclic compound binding | 341 | 4.47117E-09 |
B | |||
Biological Process | |||
GO:0009987 | cellular process | 1732 | 0.000468457 |
GO:0008152 | metabolic process | 1280 | 0.000101041 |
GO:0065007 | biological regulation | 1226 | 0.039474247 |
GO:0044238 | primary metabolic process | 1179 | 0.011728824 |
GO:0044237 | cellular metabolic process | 1153 | 0.011728824 |
GO:0050789 | regulation of biological process | 1150 | 0.022891558 |
GO:0050794 | regulation of cellular process | 1100 | 0.023393923 |
GO:0002376 | immune system process | 265 | 3.49438E-08 |
GO:0006955 | immune response | 161 | 7.5883E-06 |
GO:0022402 | cell cycle process | 151 | 0.001985807 |
Cellular Component | |||
GO:0044464 | cell part | 1699 | 1.61069E-32 |
GO:0005623 | cell | 1699 | 1.89406E-32 |
GO:0005622 | intracellular | 1506 | 1.8551E-26 |
GO:0044424 | intracellular part | 1426 | 4.89384E-25 |
GO:0043226 | organelle | 1212 | 8.24637E-20 |
GO:0043229 | intracellular organelle | 1208 | 2.30659E-19 |
GO:0043227 | membrane-bounded organelle | 1089 | 8.12018E-21 |
GO:0043231 | intracellular membrane-bounded organelle | 1088 | 5.50768E-21 |
GO:0005737 | cytoplasm | 1079 | 5.97213E-18 |
GO:0044444 | cytoplasmic part | 836 | 2.48602E-11 |
Molecular Function | |||
GO:0005488 | binding | 1748 | 3.63499E-36 |
GO:0005515 | protein binding | 1408 | 1.06202E-38 |
GO:0003824 | catalytic activity | 743 | 5.00132E-07 |
GO:0043167 | ion binding | 410 | 2.18765E-06 |
GO:0043169 | cation binding | 408 | 2.81762E-06 |
GO:0046872 | metal ion binding | 400 | 4.31756E-06 |
GO:0003676 | nucleic acid binding | 365 | 0.004482893 |
GO:0036094 | small molecule binding | 335 | 6.20944E-06 |
GO:0000166 | nucleotide binding | 309 | 2.81002E-05 |
GO:0097159 | organic cyclic compound binding | 309 | 2.91504E-05 |
KEGG pathways | Target genes | Differentially expressed microRNAs | FDR |
---|---|---|---|
T cell receptor signaling pathway | CTLA4, FYN, IKBKG, NFATC2, NCK1, CD8A, PIK3CG, CDC42, PTPN6, CD4, CD40LG, ICOS, PIK3R5, MAPK14, TNF, MAP3K7 | miR-10b, miR-9, miR-30a-5p, miR-17-5p, miR-16, miR-18a, miR-19b, miR-20a, miR-19a, miR-122, miR-146b, miR-55-5p, miR-181a, miR-196b, let-7 g, let-7c | 8.89308E-12 |
Toll-like receptor signaling pathway | CTSK, TLR7, MAP3K7, MAPK14, CXCL9, PIK3CG, NFKB1, CD40, STAT1, IL12B, CD86, IL6 | miR-10b, miR-9, miR-30a-5p, miR-17-5p, miR-16, miR-18a, miR-19b, miR-20a, miR-21, miR-19a, miR-122, miR-146b, miR-155-5p, miR-181a, miR-196b, let-7 g, let-7c | 1.04578E-07 |
NF-kappaB signaling pathway | MAP3K7, CXCL12, DDX58, LCK, XIAP, ATM, VCAM1, NFKB1, TNF, CD40LG | miR-10b, miR-9, miR-30a-5p, miR-17-5p, miR-16, miR-18a, miR-19b, miR-20a, miR-19a, miR-122, miR-146b, miR-155-5p, miR-181a, miR-196b | 1.18108E-06 |
RIG-I-like receptor signaling pathway | MAP3K7, MAPK14, DHX58, DDX58, IKBKG, TANK, IKBKB, DDX3X, NFKB1, TNF, IL12B | miR-10b, miR-9, miR-30a-5p, miR-17-5p, miR-16, miR-18a, miR-19b, miR-21, miR-19a, miR-122, miR-146b, miR-155-5p, miR-181a, let-7c | 1.70355E-05 |
Jak-STAT signaling pathway | JAK2, STAT4, STAT5B, JAK3, PIK3CG, PIM1, PTPN6, TYK2, MAPK14, STAT4, STAT1, IL7R, IL12B, IL6, PIK3R5, MYC | miR-9, miR-17-5p, miR-16, miR-18a, miR-19b, miR-20a, miR-21, miR-19a, miR-122, miR-146b, miR-155-5p, miR-181a, miR-196b, let-7 g, let-7c | 0.000124339 |
NOD-like receptor signaling pathway | MAP3K7, MAPK14, IKBKG, IKBKB, NFKB1, TNF, IL6 | miR-10b, miR-9, miR-17-5p, miR-16, miR-18a, miR-19b, miR-19a, miR-122, miR-146b, miR-155-5p, miR-181a, let-7 g, let-7c | 0.001546381 |